What are the treatment options for colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Colitis

Treatment of colitis should be guided by disease type, extent, and severity, with aminosalicylates as first-line therapy for mild to moderate ulcerative colitis, corticosteroids for non-responsive cases, and biologics or immunomodulators for moderate to severe disease. 1

Classification and Initial Assessment

The treatment approach depends on:

  1. Type of colitis (ulcerative colitis vs. Crohn's disease vs. infectious colitis)
  2. Disease extent (proctitis, left-sided, or extensive colitis)
  3. Disease severity (mild, moderate, or severe)

Disease Severity Assessment

  • Mild to moderate: <6 bloody stools/day, no systemic toxicity
  • Severe: ≥6 bloody stools/day plus at least one of: tachycardia >90 bpm, temperature >37.8°C, hemoglobin <10.5 g/dl, or ESR >30 mm/h (or CRP >30 mg/l) 1

Treatment Algorithm by Disease Extent and Severity

1. Proctitis (Distal Disease)

First-line therapy:

  • Topical mesalamine 1g suppository daily combined with oral mesalamine 2-4g daily 1
  • Topical mesalamine is more effective than topical steroids 1

For refractory proctitis:

  • Add topical corticosteroids
  • If no response, oral prednisolone 40mg daily 1
  • If still refractory, consider systemic steroids, immunosuppressants, and/or biologics 1

2. Left-Sided or Extensive Colitis

Mild to Moderate Disease:

  • Oral mesalamine 4-4.8g daily (start at full dose rather than escalating) 1, 2
  • For left-sided disease, add topical mesalamine therapy 1

Moderate to Severe Disease:

  • Oral corticosteroids (prednisolone 40mg daily) 1
  • Taper gradually over 8 weeks based on response 1

Steroid-Dependent Disease:

  • Thiopurines (azathioprine) 1
  • Anti-TNF therapy (infliximab, adalimumab, golimumab) - preferably combined with thiopurines for infliximab 1
  • Vedolizumab 1
  • Methotrexate 1

3. Severe Acute Colitis

Requires hospitalization with:

  • Daily physical examination
  • Monitoring vital signs four times daily
  • Stool chart recording
  • Regular blood tests (FBC, ESR/CRP, electrolytes, albumin)
  • Abdominal radiography if colonic dilatation present 1

Initial treatment:

  • IV corticosteroids (hydrocortisone 400mg/day or methylprednisolone 60mg/day) 1
  • IV fluid and electrolyte replacement
  • Blood transfusion to maintain hemoglobin >10 g/dl
  • Subcutaneous heparin for thromboprophylaxis
  • Nutritional support if malnourished 1

If no improvement within 3 days:

  • Consider second-line therapy with either:
    • Infliximab (5mg/kg) 1, 3
    • Ciclosporin (2mg/kg/day IV) 1

Indications for emergency surgery:

  • No improvement after 48-72 hours of medical therapy
  • No response to second-line therapy after 4-7 days
  • Complications: toxic megacolon, perforation, massive hemorrhage 1, 4
  • Subtotal colectomy with ileostomy is the preferred emergency procedure 1

Special Considerations

Infectious Colitis

  • Rule out infectious causes with stool cultures and C. difficile testing before initiating immunosuppressive therapy 1, 5
  • If C. difficile is detected, treat with oral vancomycin 1

Maintenance Therapy

  • Lifelong maintenance therapy is generally recommended, especially for left-sided or extensive disease 1
  • Aminosalicylates are first-line maintenance therapy 1
  • For those requiring biologics or immunomodulators for induction, these should be continued for maintenance 1

Treatment Monitoring

  • Regular assessment of clinical response
  • Endoscopic evaluation to confirm mucosal healing
  • Monitor for medication side effects
  • Adjust therapy if expected improvement goals are not reached 1

Common Pitfalls to Avoid

  1. Delayed surgical consultation in severe colitis - early surgical referral is crucial as colectomy may be life-saving 1, 4

  2. Inadequate initial dosing of aminosalicylates - start with full therapeutic doses (4.8g/day) rather than low doses 2

  3. Prolonged steroid use without steroid-sparing strategies - implement thiopurines or biologics early in steroid-dependent disease 1

  4. Failure to identify alternative explanations for refractory symptoms:

    • Poor medication adherence
    • Inadequate drug delivery
    • Proximal constipation
    • Unrecognized infection
    • Incorrect diagnosis (IBS, Crohn's disease) 1
  5. Delaying surgery when indicated - prolonged observation in non-responsive severe colitis increases risk of toxic megacolon and perforation 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ulcerative colitis: responding to the challenges.

Cleveland Clinic journal of medicine, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.